DYSIS Colposcope with DYSISmap™
Cervical cancer screening and diagnosis; Detection of Cervical Intraepithelial Neoplasia (CIN)
CommercialMarketed
Key Facts
Indication
Cervical cancer screening and diagnosis; Detection of Cervical Intraepithelial Neoplasia (CIN)
Phase
Commercial
Status
Marketed
Company
About DYSIS Medical
DYSIS Medical is a forward-looking medtech company focused on transforming cervical cancer screening through its innovative computer-aided colposcopy technology. Founded in 2002, the company's FDA-cleared and CE-marked DYSIS Colposcope enhances the accuracy of lesion detection by providing an objective, color-coded map of the cervix. With strong clinical validation from over 5,500 exams, a favorable NICE recommendation in the UK, and adoption in both private practices and public health systems, DYSIS is positioned to improve standard-of-care in a critical area of women's health.
View full company profile